Artificial Intelligence Shakes Up Drug Discovery
Artificial Intelligence Shakes Up Drug Discovery
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
Artificial Intelligence Shakes Up Drug Discovery
Artificial Intelligence Shakes Up Drug Discovery

The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.

The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.

biotech
AI App Identifies Rare Genetic Disorders from Photos of Patients’ Faces
AI App Identifies Rare Genetic Disorders from Photos of Patients’ Faces
Catherine Offord | Jan 8, 2019
Deep-learning algorithms could help doctors narrow in on the causes of certain medical conditions, say researchers.
<em>Genesis 2.0</em> Is a Beautifully Shot, Cautionary Tale About Biotechnology
Genesis 2.0 Is a Beautifully Shot, Cautionary Tale About Biotechnology
Shawna Williams | Jan 2, 2019
The documentary weaves together a hunt for mammoth tusks in the Arctic with scenes from the front lines of synthetic biology.
Zimbabwe&rsquo;s Medical Marijuana Future Uncertain
Zimbabwe’s Medical Marijuana Future Uncertain
Tonderayi Mukeredzi | Sep 12, 2018
The country is the second in Africa to permit cannabis cultivation, but months after approval there’s been little uptake by farmers and no scientific proposals.
Synthetic Bacteria Help Treat Phenylketonuria in MiceSynthetic Bacteria Help Treat Phenylketonuria in Mice
Synthetic Bacteria Help Treat Phenylketonuria in Mice
Diana Kwon | Aug 17, 2018
The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.
CRISPR Patent Dispute Heard in Federal Court
CRISPR Patent Dispute Heard in Federal Court
Jim Daley | May 1, 2018
In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.
Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals
Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals
Jim Daley | Jan 31, 2018
Biotech stocks fell in response to the news. 
Equivocal Findings of Alzheimer’s Trial Using Young Blood
Equivocal Findings of Alzheimer’s Trial Using Young Blood
Catherine Offord | Nov 6, 2017
A team of Stanford University researchers say that administering young people’s blood plasma to Alzheimer’s patients could improve cognitive function, but the results have been criticized.
Flux and Uncertainty in the CRISPR Patent Landscape
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
Was a Drop in CRISPR Firms’ Stock Warranted?
Was a Drop in CRISPR Firms’ Stock Warranted?
Claire Asher | Jun 7, 2017
A study of off-target effects that sparked fear among investors of genome-editing companies receives methodological criticisms.